Rapid antimicrobial susceptibility testing for gram-negative blood infections shows no improvement in clinical outcomes ...

Among patients with gram-negative bacilli bloodstream infections, rapid blood culture antimicrobial susceptibility testing was not superior to standard testing by desirability of outcome ranking. When ...

Trial comes up negative, but shorter hospital stays observed in carbapenem-resistant cases ...

Even when bacteria appear susceptible in routine tests, tolerance can let them survive therapy long enough to drive ...

A new study published in the Journal of the American Medical Association revealed that rapid blood culture antimicrobial ...

An international trial found that rapid antimicrobial susceptibility testing (AST) for gram-negative bloodstream infections did not significantly improve 30-day survival or other major clinical ...

The microbiology business provides antimicrobial susceptibility testing and culture media solutions for clinical, ...

Rapid diagnostics are reshaping infectious diseases care, but their value depends on more than speed alone, as Gerry Hughes ...

Thermo Fisher Scientific Inc. agreed to sell its microbiology business to Astorg, a private equity firm, for approximately $1.075 billion, consisting of cash and a $50 million seller note. The ...

Thermo Fisher Scientific has struck a deal to sell its microbiology business to European private-equity firm Astorg for about ...